Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes - Wikidata - awgldk - TriplyDB

Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes

Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes

http://www.wikidata.org/entity/Q35576287

about

Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics Diamond Nanoparticles Modify Curcumin Activity: In Vitro Studies on Cancer and Normal Cells and In Ovo Studies on Chicken Embryo Model Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer.Antimicrobial activity of cationic peptides in endodontic procedures.The roles of cellular nanomechanics in cancer.Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles.Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications.Effects of polymer molecular weight on relative oral bioavailability of curcumin.Curcumin nanomedicine: a road to cancer therapeutics Enhanced photocytotoxicity of curcumin delivered by solid lipid nanoparticles Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment Nanotechnology-applied curcumin for different diseases therapy.Investigations on agglomeration and haemocompatibility of vitamin E TPGS surface modified berberine chloride nanoparticles Nanoformulations of curcumin: an emerging paradigm for improved remedial application.Presenting a New Standard Drug Model for Turmeric and Its Prized Extract, Curcumin.

P2860

Q27026623-0F439F18-0286-44AD-A764-6B3553CA7AF1 Q28554730-3C4313E6-004A-45CB-AAEE-FA1D8CE60CD8 Q34454413-ED461AC4-09EA-41DC-B305-2F1F3A03EE90 Q35195248-402DAB7D-6817-4726-8599-345A6745916B Q35343806-927A1ACC-01A0-4337-86C9-2180F5653667 Q35343983-FDD5E999-32B0-4912-957B-54B5E64834D2 Q35972616-C19EAF33-FAA4-4A86-BE18-2102070E01D2 Q36061993-62014F76-D8BF-4E54-BED3-2A9F1BF14E0E Q36807261-471B6C2D-BB0F-4303-8775-C0B6B4998A92 Q37538150-8A3E3B7C-B838-4347-963E-8B5888DC7E7B Q37662418-0C77677B-DB62-49EC-884A-CD33C081B86E Q40997969-A845122C-4937-4585-BE5C-7D3700B60924 Q41968953-22FF4E84-BEDE-4382-94BB-3A7AA7D2F49C Q42371683-B5C71213-E785-45AD-A484-704CA830A417 Q52641505-9A2E0B6E-5972-43DF-8A2F-44BF6429811A

P2860

Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes

http://www.wikidata.org/entity/Q35576287

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes

@ast

Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes

@en

type

label

Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes

@ast

Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes

@en

prefLabel

Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes

@ast

Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes

@en

P1433

Q35576287-677A5D79-0F07-4C1A-B1DC-C6A4F3035ADA

P1476

Q35576287-829854B2-C943-46CA-A1B7-51FB8D470722

P2093

Q35576287-5D290725-AD5E-4C2E-9C4E-7727CF69F4E6

Q35576287-8B5BDA23-93EB-42A3-945F-FB4D3508F42C

Q35576287-99C5A3FF-7FC8-49F6-9EDD-F9AD0C5B4312

Q35576287-A321DC47-5686-4CF1-8471-D2A0586BB126

Q35576287-FC6D321A-9C39-4D79-B3B1-B5FA0F04A9DB

P2860

Q35576287-0750D38C-D626-42FE-B98F-276170A17BEE

Q35576287-1661F230-0FBB-422D-8D61-C01A79857596

Q35576287-17A6953E-21CC-476A-BB0B-499071AB77D9

Q35576287-1AB8E572-060D-4F14-891B-547CFBABF19D

Q35576287-1CF2416E-4BD3-4463-B432-55B6627BA60F

Q35576287-1D00B178-17AE-47E2-867A-73D059435635

Q35576287-24BE75D7-46C3-45B7-B493-952E0123AC9B

Q35576287-2A1C9D68-C7F2-4577-987D-F6A0E3038868

Q35576287-32342847-980B-4EC7-8925-8A736C6C8DB0

Q35576287-34BA44AD-8130-46C7-9638-6857983FEF04

P304

Q35576287-FE64A81A-8D4D-4816-B4A1-FCB5B575C760

P31

Q35576287-BB630865-9D5C-417F-9A54-83D51EECCFFF

P356

Q35576287-69E9C5B3-5E6D-41AA-8562-B9039A271510

P407

Q35576287-46B68646-0418-4F75-B389-E1D2F5789645

P478

Q35576287-C08ED82B-DFC1-47FE-9E10-3FD2172E5EF9

P577

Q35576287-5AC58AB2-1548-41F6-9DC7-11BEFF8BF780

P698

Q35576287-3D78AB9C-A5D4-4B4A-84F8-7F48CD5CEB5D

P921

Q35576287-47d4253a-a0a0-4790-83c3-50943a2755fb

P932

Q35576287-02A79B49-94F7-48BF-830F-C2196F4663F5

P356

P1433

International Journal of Nanomedicine

P1476

Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes

@en

P2093

Mara C Ebeling

http://www.w3.org/2001/XMLSchema#string

Meena Jaggi

http://www.w3.org/2001/XMLSchema#string

Murali Mohan Yallapu

http://www.w3.org/2001/XMLSchema#string

Neeraj Chauhan

http://www.w3.org/2001/XMLSchema#string

Subhash C Chauhan

http://www.w3.org/2001/XMLSchema#string

P2860

Bioavailability of curcumin: problems and promises

Therapeutic nanoparticles for drug delivery in cancer

Interaction of gold nanoparticles with common human blood proteins.

Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo.

beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells.

Biochemical localization of hepatic surface-membrane Na+,K+-ATPase activity depends on membrane lipid fluidity.

PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications.

Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth.

In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis.

Multiple biological activities of curcumin: a short review.

P304

2779-2790

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S25534

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22128249

http://www.w3.org/2001/XMLSchema#string

P921

P932

3225220

http://www.w3.org/2001/XMLSchema#string